Cargando…

Comparative Efficacy of Different Drugs for the Treatment of Dilated Cardiomyopathy: A Systematic Review and Network Meta-analysis

BACKGROUND AND OBJECTIVE: At present, the therapies of dilated cardiomyopathy concentrated on the symptoms of heart failure and related complications. The study is to evaluate the clinical efficacy of a combination of various conventional and adjuvant drugs in treating dilated cardiomyopathy via net...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tong, Xinyu, Shen, Lijuan, Zhou, Xiaomin, Wang, Yudan, Chang, Sheng, Lu, Shu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2023
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10439079/ https://www.ncbi.nlm.nih.gov/pubmed/37556093 http://dx.doi.org/10.1007/s40268-023-00435-5

Ejemplares similares

Peripartum cardiomyopathy and dilated cardiomyopathy: different at heart
por: Bollen, Ilse A. E., et al.
Publicado: (2015)

Drug Therapy in Dilated Cardiomyopathy and Myocarditis
por: Barron, Hal
Publicado: (1989)

Histopathologic features of alcoholic cardiomyopathy compared with idiopathic dilated cardiomyopathy
por: Li, Xuebiao, et al.
Publicado: (2018)

Construction of Immune-Related ceRNA Network in Dilated Cardiomyopathy: Based on Sex Differences
por: Liu, Chang, et al.
Publicado: (2022)

Dilated cardiomyopathy
por: Schultheiss, Heinz-Peter, et al.
Publicado: (2019)

Efficacy and safety of stem cell therapy in patients with dilated cardiomyopathy: a systematic appraisal and meta-analysis
por: Rong, Shu-Ling, et al.
Publicado: (2019)

Efficacy of L-Carnitine for Dilated Cardiomyopathy: A Meta-Analysis of Randomized Controlled Trials
por: Weng, Yayun, et al.
Publicado: (2021)

Genomic Context Differs Between Human Dilated Cardiomyopathy and Hypertrophic Cardiomyopathy
por: Puckelwartz, Megan J., et al.
Publicado: (2021)

Shared Genetic Etiology of Primary Dilated Cardiomyopathy and Ischemic Dilated Cardiomyopathy
por: Sun, Yang, et al.
Publicado: (2021)

Long-Term Outcomes of Tachycardia-Induced Cardiomyopathy Compared with Idiopathic Dilated Cardiomyopathy
por: Katz, Moshe, et al.
Publicado: (2023)

Left ventricular strain echocardiography in advanced uremic cardiomyopathy compared to dilated cardiomyopathy
por: Mohammadi, Rizan, et al.
Publicado: (2023)

Evaluation of Drug-Related Receptors in Children With Dilated Cardiomyopathy
por: Guo, Qing, et al.
Publicado: (2019)

Dilated Cardiomyopathy: Beware of Diet Drugs Slimming the Heart
por: Bhattad, Pradnya Brijmohan, et al.
Publicado: (2023)

Dilated cardiomyopathies and non-compaction cardiomyopathy
por: Hänselmann, A., et al.
Publicado: (2020)

Cardiomyopathy, familial dilated
por: Taylor, Matthew RG, et al.
Publicado: (2006)

Dilated cardiomyopathy in childhood
por: Franklin, OM, et al.
Publicado: (2000)

Immunoadsorption in dilated cardiomyopathy
por: Wakabayashi, Y, et al.
Publicado: (2009)

Apoptosis in Dilated Cardiomyopathy
por: Hong, Bum Kee, et al.
Publicado: (2000)

Clinical efficacy of carvedilol treatment for dilated cardiomyopathy: A meta-analysis of randomized controlled trials
por: Li, Tao, et al.
Publicado: (2019)

Speckle tracking echocardiography in hypokinetic non‐dilated cardiomyopathy: comparison with dilated cardiomyopathy
por: Mombeini, Hoda, et al.
Publicado: (2020)

Sex Differences, Genetic and Environmental Influences on Dilated Cardiomyopathy
por: Jain, Angita, et al.
Publicado: (2021)

Sex and gender differences in myocarditis and dilated cardiomyopathy: An update
por: Fairweather, DeLisa, et al.
Publicado: (2023)

Differences between familial and sporadic dilated cardiomyopathy: ESC EORP Cardiomyopathy & Myocarditis registry
por: Asselbergs, Folkert W., et al.
Publicado: (2020)

Different expression and prognostic value of troponin in ischemic cardiomyopathy and non-ischemic dilated cardiomyopathy
por: Gao, Wei, et al.
Publicado: (2023)

A circular network of purine metabolism as coregulators of dilated cardiomyopathy
por: Wang, Ge, et al.
Publicado: (2022)

Plasma Metabolomic Profiles Differentiate Patients With Dilated Cardiomyopathy and Ischemic Cardiomyopathy
por: Zhao, Junhan, et al.
Publicado: (2020)

The role of Asprosin in patients with dilated cardiomyopathy
por: Wen, Ming-Shien, et al.
Publicado: (2020)

Hypoparathyroidism and reversible dilated cardiomyopathy
por: Babu, M. Suresh, et al.
Publicado: (2011)

The Mutations Associated with Dilated Cardiomyopathy
por: Parvari, Ruti, et al.
Publicado: (2012)

Calreticulin Induces Dilated Cardiomyopathy
por: Lee, Dukgyu, et al.
Publicado: (2013)

Infants with dilated cardiomyopathy and hypocalcemia
por: Sanyal, Debmalya, et al.
Publicado: (2013)

LMNA-related dilated cardiomyopathy
por: Vaikhanskaya, Tatiyana, et al.
Publicado: (2014)

Rhinovirus-associated dilated cardiomyopathy
por: Chow, Jeffrey, et al.
Publicado: (2020)

Myocarditis and idiopathic dilated cardiomyopathy
por: Brown, Charles A., et al.
Publicado: (1995)

Echocardiographic Advances in Dilated Cardiomyopathy
por: Faggiano, Andrea, et al.
Publicado: (2021)

Transcriptomics and Beyond in Dilated Cardiomyopathy
por: Cowan, Jason R., et al.
Publicado: (2023)

The Genetic Evaluation of Dilated Cardiomyopathy
por: Bui, Quan M., et al.
Publicado: (2023)

Cushing Syndrome in the Setting of Chronic Dilated Cardiomyopathy: Can Treatment Improve Chronic Dilated Cardiomyopathy?
por: Pathak, Leilani, et al.
Publicado: (2021)

Elevated Serum Bisphenol A Level in Patients with Dilated Cardiomyopathy
por: Xiong, Qinmei, et al.
Publicado: (2015)

Sex‐ and age‐based differences in the natural history and outcome of dilated cardiomyopathy
por: Halliday, Brian P., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_fi8tpg2u4893qvvrspjcke8rjb